TY  - JOUR
AU  - Benito León, María
AU  - Gil Redondo, Juan Carlos
AU  - Pérez Sen, Raquel
AU  - García Delicado, Esmerilda
AU  - Ortega De La O, Felipe
AU  - Gómez Villafuertes, María Rosa
PY  - 2022
DO  - 10.3389/fcell.2022.1049566
UR  - https://hdl.handle.net/20.500.14352/128624
T2  - Frontiers in Cell and Developmental Biology
AB  - P2X7 receptor (P2RX7) is expressed strongly by most human cancers, including neuroblastoma, where high levels of P2RX7 are correlated with a por prognosis for patients. Tonic activation of P2X7 receptor favors cell metabolism and angiogenesis, thereby...
LA  - eng
M2  - 01
PB  - Frontiers
KW  - P2X7 receptor
KW  - neuroblastoma
KW  - DUSP1
KW  - p38 phosphorylation,
KW  - Sp1 transcription factor
KW  - phosphatase inhibitor
KW  - BCI
TI  - BCI, an inhibitor of the DUSP1 and DUSP6 dual specificity phosphatases, enhances P2X7 receptor expression in neuroblastoma cells.
TY  - journal article
VL  - 10
ER  -